In early epidemiological studies, lower serum albumin concentrations were associated with an increased risk of cancer-related mortality; further, in gastrointestinal malignancies such as colorectal, gastric and hepatocellular carcinoma, low albumin has been found to be a poor prognostic indicator of survival [28–30]. The gene discussed is ALB; the disease is cancer.